Kiromic Biopharma Inc (KRBP) — Financial Flexibility Index
Kiromic Biopharma Inc (KRBP) has a Financial Flexibility Index of -0.17x as of December 2024. Free cash flow of $-3.62 Million (operating CF $-3.65 Million minus capex $28.00K) represents 0% of total liabilities ($21.13 Million). Also explore KRBP net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kiromic Biopharma Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Kiromic Biopharma Inc across 7 annual periods. Check Kiromic Biopharma Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kiromic Biopharma Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Kiromic Biopharma Inc. For the full company profile including market capitalisation, see KRBP company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.90x | $-19.09 Million | $-19.46 Million | $21.13 Million | ▲ +8.5% |
| 2023 | -0.99x | $-21.02 Million | $-21.23 Million | $21.29 Million | ▲ +7.2% |
| 2022 | -1.06x | $-18.87 Million | $-23.75 Million | $17.74 Million | ▲ +80.3% |
| 2021 | -5.40x | $-18.43 Million | $-20.32 Million | $3.41 Million | ▼ -69.9% |
| 2020 | -3.18x | $-4.67 Million | $-6.13 Million | $1.47 Million | ▲ +17.9% |
| 2019 | -3.88x | $-2.61 Million | $-2.91 Million | $673.70K | ▼ -17.4% |
| 2018 | -3.30x | $-2.02 Million | $-2.15 Million | $610.70K | — |